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ABSTRACT
Common sequence variants within a gene often generate important differences in expression of
corresponding mRNAs. This high level of local (allelic) control—or cis modulation—rivals that produced
by gene targeting, but expression is titrated finely over a range of levels. We are interested in exploiting
this allelic variation to study gene function and downstream consequences of differences in expression
dosage. We have used several bioinformatics and molecular approaches to estimate error rates in the
discovery of cis modulation and to analyze some of the biological and technical confounds that contribute
to the variation in gene expression profiling. Our analysis of SNPs and alternative transcripts, combined
with eQTL maps and selective gene resequencing, revealed that between 17 and 25% of apparent cis
modulation is caused by SNPs that overlap probes rather than by genuine quantitative differences in
mRNA levels. This estimate climbs to 40–50% when qualitative differences between isoform variants are
included. We have developed an analytical approach to filter differences in expression and improve the
yield of genuine cis-modulated transcripts to 80%. This improvement is important because the resulting
variation can be successfully used to study downstream consequences of altered expression on higher-
order phenotypes. Using a systems genetics approach we show that two validated cis-modulated genes,
Stk25 and Rasd2, are likely to control expression of downstream targets and affect disease susceptibility.
VARIATION in gene expression contributes tophenotypic diversity and has an impact on disease
susceptibility. Early biochemical studies revealed heri-
table variation in levels of b-glucuronidase between
strains of mice and their intercross progeny (Morrow
et al. 1949; Law et al. 1952). The first linkage study of
this type demonstrated that esterase activity in maize
was modulated by a locus tightly linked to the esterase
gene itself (Schwartz 1962). Three decades later,
Damerval et al. (1994) made a breakthrough by ap-
plying proteomic methods to the same fundamental
problem. They quantified expression differences of 72
proteins in an F2 intercross and simultaneously mapped
40 quantitative trait loci (QTL) that modulated the
expression of different isoforms. The advent of high-
throughput microarray technology made it practical to
apply sophisticated QTL mapping methods to simulta-
neously map expression quantitative trait loci (eQTL)
that potentially control the expression of thousands of
transcripts in yeast, plant, and animal populations
(Cavalieri et al. 2000; Karp et al. 2000; Brem et al.
2002; Schadt et al. 2003; Monks et al. 2004; Morley et al.
2004; Chesler et al. 2005; Hubner et al. 2005; Dixon
et al. 2007; Goring et al. 2007; Stranger et al. 2007).
Genetic variation in expression is produced by mech-
anisms that act either in cis or in trans. Cis effects refer to
local polymorphisms or alleles that influence the
synthesis or stability of a gene’s own message. When
this type of variation is mapped, the regulatory locus
coincides with the position of the source gene. Previous
studies of gene expression have shown that a great
majority of transcripts that have highly significant QTL
are potentially cis-modulated (e.g., Chesler et al. 2005;
Peirce et al. 2006). Surprisingly, in our own work we
found that there was more than a twofold excess of cis-
modulated transcripts in which the allele associated
with high expression was inherited from strain C57BL/
6J—the strain used for almost all genome sequencing,
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EST discovery, and array design. In contrast, we did not
detect any significant allelic imbalance for QTL associ-
ated with trans effects. This imbalance highlighted a
systematic bias in the detection of a problematic subclass
of cis-modulated transcripts associated with sequence
differences that affect probe–target hybridization.
In this study we have applied several systematic
approaches to estimate error rates in the discovery of
cis-modulated transcripts and to explore some of the
biological and technical confounds that contribute to
expression variation. While this study is by no means the
first to point out the potential difficulty of sorting out
sources of variation in array hybridization (Schadt et al.
2003; Alberts et al. 2005, 2007, 2008; Doss et al. 2005;
Chen et al. 2009), we have extended previous work in
three ways. First, we provide a comparatively quantita-
tive assessment of the severity of the problem for two
of the preeminent array platforms (Affymetrix and
Illumina) by exploiting several large expression data
sets and allele-specific expression protocols. Second, we
have found that variation in 39-UTR structure generates
serious technical confounds even in the absence of
sequence differences that overlap probe sequences.
Third, we introduce a relatively simple protocol that
can significantly increase the detection of true cis-
expression differences. Our analysis is motivated by
two factors. First, once cis-modulated transcripts have
been validated, they become molecular resources to
study downstream consequences of altered gene ex-
pression. Second, these variants are particularly amena-
ble to detailed molecular analysis and their dissection
will lead to a more complete understanding of the allelic
modulation of gene expression.
MATERIALS AND METHODS
Microarray expression profiling: Measurement of mRNA
expression relied on multiple brain tissues collected from
strains C57BL/6J (B6) and DBA/2J (D2), their reciprocal F1
hybrids (B6D2F1 and D2B6F1), and BXD recombinant inbred
(RI) strains. We used data sets consisting of 39 BXD strains for
the whole brain (Peirce et al. 2006), 67 for the hippocampus
(Overall et al. 2009), and 54 for the striatum (Rosen et al.
2009). These studies exploited the most widely used mouse
arrays: the Affymetrix Mouse Genome 430A–430B array pair to
profile the whole brain, the Affymetrix Mouse Genome 430 2.0
array to profile the hippocampus, and the Illumina MouseWG-
6 v1.1 array to profile the striatum. Affymetrix microarray data
used in this study were normalized using the position-
dependent nearest neighbor (PDNN) method (Zhang et al.
2004) but data normalized using robust multiarray average
(RMA) and microarray analysis system 5 (MAS 5) procedures
give similar results. We have also used an unpublished but
open data set from the hippocampus of 72 BXD strains, the
2 parental strains, and F1 hybrids profiled using the Affymetrix
Mouse Exon 1.0 ST array (see www.genenetwork.org/dbdoc/
UMUTAffyExon_0209_RMA.html). Illumina microarray data
were normalized using the vendor’s rank invariant method.
Additional information about the BXD panel, experimen-
tal procedures, and data sets used can be obtained from
GeneNetwork information pages (www.genenetwork.org).
Genotyping and QTL mapping: We used 3785 informative
SNPs and microsatellite markers to map expression traits in
the BXD strain panel. QTL mapping was performed using
QTL Reaper as described (Peirce et al. 2006). The location of
the probes was identified using the February 2006 assembly
and the University of California, Santa Cruz (UCSC) genome
browser (http://genome.ucsc.edu).
SNPs data set: We used SNPs extracted from the SNPs data-
base and variant browser of GeneNetwork (www.genenetwork.
org/webqtl/snpBrowser.py) to analyze the impact of SNPs on
expression level. This database incorporates the majority of
previously known Celera and Perlegen SNPs available in NCBI
Entrez dbSNP. The number of informative SNPs between B6 and
D2 used in our screening was 1.8 million, although we have
recently added an additional set of .1 million SNPs from an
ongoing sequencing project.
Isoform mRNA detection: Our analysis is based on several
sources of data: mouse genome assembly and EST sequences
were downloaded from UCSC (ftp://hgdownload.cse.ucsc.
edu/goldenPath/mm8/), and mouse full-length cDNAs were
obtained from NCBI (www.ncbi.nlm.nih.org) and RIKEN
databases (http://genome.gsc.riken.go.jp). We used the fol-
lowing steps to identify mRNA isoforms: (1) we aligned the
ESTs and cDNA sequences to the mouse genome sequence
using BLAT (Kent 2002), (2) we extracted the genome
sequences that matched each EST/cDNA sequence and up
to 5 kb of the flanking sequence, (3) we aligned the
EST/cDNA sequences with the highest BLAT scores to the
genome sequence using SIM4 software (Florea et al. 1998) to
infer exon/intron boundaries, and (4) we compared the
predicted gene structures for each EST/cDNA and identified
potential mRNA isoforms.
Allelic specific expression analysis: We carried out allelic
specific expression (ASE) analysis in reciprocal F1 individuals
(C57BL/6J3 DBA/2J) by combining RT–PCR with SNaPshot
(Applied Biosystems, Foster City, CA). PCR primers were
designed in the same exon flanking the informative SNPs
using Primer 3 (supporting information, Table S1) (Rozen
and Skaletsky 2000). We selected the most appropriate side
of the SNPs to design SNaPshot extension primers. Hippo-
campal tissue was collected from F1 mice averaging 60 days old
as in the previous microarray experiments (Chesler et al.
2005; Peirce et al. 2006). RNA was isolated from pools of two to
four hippocampi using RNA-STAT 60 (Tel-Test) and quanti-
fied by a NanoDrop ND-1000 spectrophotometer. We set up
four RNA pools, one per each sex and reciprocal cross. The
number of individuals in each RNA pool varied from four to
eight. We isolated individual DNA from the spleen of four
different heterozygote individuals using a standard phenol-
chloroform procedure. These DNA samples were used as
controls and tested at the same time with the RNA pools. We
treated the RNA with Turbo DNase (Ambion) to degrade any
traces of genomic DNA. The absence of genomic DNA
contamination was confirmed by PCR across small introns.
First-strand cDNA synthesis (GE Healthcare) of the RNA
pools was followed by PCR of the cDNA and genomic DNA
samples (GoTaq Flexi DNA polymerase; Promega, Madison,
WI). The PCR products were purified using ExoSap-IT
(United States Biochemical, Cleveland) and used in the
SNaPshot reaction. SNaPshot extension products were puri-
fied by calf intestinal phosphatase (New England Biolabs,
Beverly, MA) and separated by capillary electrophoresis using
ABI3130 (Applied Biosystems). We analyzed the quantifica-
tion results using GeneMapper v4.0 software (Applied Bio-
systems). We used the peak heights corresponding to
each allele as a measure of allelic abundance. We tested for
the presence of ASE difference using a t-test to compare the
logarithm of the allelic fold change between cDNA and the
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genomic DNA. We estimated fold difference in expression as
the ratio of allelic fold difference in cDNA to the genomic DNA.
qRT-PCR analysis: Dorsal striatum was dissected from four
C57BL/6J and DBA/2J mice and total RNA was extracted using
RNA-STAT 60. We treated the RNA pools with Turbo DNase.
cDNA synthesis was performed on equal amounts of total RNA,
using the First-Strand cDNA Synthesis kit and the NotI-d(T)18
primer (GE Healthcare). We selected the qRT-PCR assays using
the Universal Probe Library (www.universalprobelibrary.com,
Roche Diagnostics) (Table S2). Two assays were designed for
each candidate transcript: one that targets the putative alter-
native region and one that targets an exon common in both
transcripts. Most of the assays designed in the nonpolymorphic
exons span an intron while assays targeting alternative regions
were designed close to the location of the microarray probe that
captured a cis effect. We used cyclophilin D as a reference gene
for comparative threshold quantification. This gene is not
differentially expressed between strains. qRT-PCR was per-
formed using the LightCycler 480 System (Roche Diagnostics)
according to the standard protocol for the LC480 Probes
Master. Standard curves for five 10-fold dilutions between
2500 and 0.25 ng of reverse-transcribed RNA samples were
run for all assays to determine PCR efficiency under experi-
mental conditions for reference and selected genes. The mean
crossing thresholds (CT) for the technical duplicates of
different amplicons were used to calculate mean normalized
expression (MNE) values that reflect the relative expression of
the target gene compared to the reference gene by taking the
efficiencies of the PCR into account (Simon 2003). MNE values
for C57BL/6J and DBA/2J were log10 transformed and com-
pared by t-tests. Mean fold difference values were calculated
using the expression of C57BL/6J as a reference.
RESULTS AND DISCUSSION
SNPs overlapping probes affect the rate of discovery
of cis QTL: Recent linkage studies of gene expression
have used commercial short oligomer probes to measure
steady-state gene expression levels in a wide variety of
tissues and species. The Affymetrix platform is based on
sets of 25-mer probes (typically 11 probes per probe set),
whereas the Illumina platforms exploit longer 50-mer
probes. We used both platforms and systematically
mapped cis- and trans-acting loci in multiple tissues of
the BXD strains. A cis-acting locus is defined here as a
QTL with a likelihood-ratio statistic (LRS) .15 (LOD .
3.26) and located within 3 Mb of the source gene. We
detected a total of 3431 Affymetrix probe sets correspond-
ing to 2640 potentially cis-modulated genes and 2944
Illumina probes corresponding to 2587 potentially cis-
modulated genes in two large CNS expression data sets.
The size and direction of additive effects for these cis-
acting QTL were imbalanced in both tissues and using
both array platforms. Approximately 65% of cis QTL
were associated with higher expression of the C57BL/6J
allele (B) relative to the DBA/2J allele (D). This is close
to a 2:1 imbalance in favor ofB alleles. If QTL are ranked
on the basis of a LRS, the imbalance is even more
pronounced among the top 10% of cis QTL: a 3:1 ratio
among Affymetrix probe sets and a 6.7:1 ratio among
Illumina probes. In contrast, the imbalance is modest
among the bottom 10% of cis QTL: 1.3:1 for both
Affymetrix and Illumina platforms. In marked contrast,
trans-modulated transcripts, which by definition are
controlled by distant sequence variants, are almost
perfectly balanced (1:1) on both platforms with respect
to effect size and polarity.
It would be important to know how many of these cis-
acting candidate QTL are genuine and how many are
caused by qualitative differences between isoforms. As
has been established for several years, SNP position and
the number of SNPs overlapping the microarray probes
have a significant impact on the discovery rate and the
size of apparent expression differences for cis- (Schadt
et al. 2003; Alberts et al., 2005, 2007; Doss et al. 2005;
Chen et al. 2009) and trans-modulated transcripts
(Chen et al. 2009). Our analysis found that the longer
Illumina 50-mers have approximately the same sensitiv-
ity to sequence differences as the shorter Affymetrix
25-mer probes (Figure S1 and Figure S2). In both cases,
SNPs that overlap at the 59 and 39 ends of the probes
perturb measurements only slightly, whereas those that
overlap more central positions have a strong effect
(Affymetrix P , 0.00002; Illumina P , 0.02). As expec-
ted, the average size of cis effects increases as a function
of the number of SNPs (P , 0.0001). In contrast, the
effect size of trans QTL is not influenced at all by SNPs
that overlap probes.
We removed from our analysis all of the probes that
overlap known SNPs but the bias in favor of B alleles was
still present among cis-acting QTL. For example, re-
moving all Illumina probes that overlap known SNPs
reduced the bias from 65 to 57%. This represents a drop
in the number of cisQTL by 17%. The residual imbalance
could be readily explained by unknown polymorphisms
that overlap probes or by isoform variation.
Alternative splicing, initiation, and termination of
transcription—qualitative changes affecting gene ex-
pression measurements: Differences in alternative splic-
ing, initiation, and termination of transcription have an
important contribution to variation in gene expression.
Recently Kwan et al. (2008) employed exon arrays and
showed that 55% of expression differences in a HapMap
population are due to isoform variations caused by
alternative splicing, initiation, and termination of tran-
scription. Expression analysis by multiple probes that
profile the same transcript provides a comprehensive
picture of the complexity of variation. Expression of
37% of genes profiled in striatum by the Illumina array
(9200 of 25,000 genes) is measured by two or more
probes. Expression of 1100 genes is characterized by a
moderately strong cis effect (LRS . 15) and measured
by multiple probes that are not affected by known SNP
variants. This enabled us to assess the consistency with
which a cis effect was detected by multiple probes.
Twenty-two percent of these 1100 genes with companion
probes had discordant cis QTL effects—strong cis QTL
detected by one or more probes and insignificant cis
effects by other probes. This discordance may be either
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due to unknown SNPs overlapping probes or due to
isoform variation. One example of the latter effect is an
apparent difference in expression of ADP-ribosylation
factor related protein 1 (Arfrp1) that is detected by a
probe that targets an alternatively spliced exon but not by
a probe that targets an exon common in all isoforms
(Figure 1).
The question at this point is what fraction of observed
cis effects is caused by unknown SNPs affecting hybrid-
ization or due to isoform variants? To address this we
resequenced a random set of 16 genes with discordant
probe pairs. We identified new SNPs overlapping probes
in only 5 of the genes (31%). In the rest of the genes
from this group we identified high levels of cis variation
specific to 39-UTRs. Two independent quantitative real-
time RT–PCR (qRT-PCR ) assays confirmed strain-
specific differences specific to 39-UTRs for 5 of the 11
tested genes (Table S3). For the remaining 6 genes the
differences were either not specific to the 39-UTR or
undetectable by qRT-PCR. For example, analysis of array
data uncovered a cis effect specific to a probe that targets
the distal end of the longest 39-UTR variant of St6galnac4
(Figure 2). In contrast, there is no cis effect for probes
that target other exons. There are at least three putative
poly(A) sites in St6galnac4 that could generate variation
in 39-UTR length (http://polya.umdnj.edu/polyadb)
(Lee et al. 2007).
Exon microarrays provide a more high-throughput
alternative to resolve the confound between quantitative
and qualitative differences in mRNA expression. We
profiled the hippocampus of the BXD panel using the
Affymetrix Mouse Exon 1.0 ST array to map loci re-
sponsible for quantitative and qualitative variation in
expression. In genes that are profiled by at least six probe
sets that target multiple exons, we found consistent
evidence (.50%) of cis and trans modulation in 282
and 271 genes, respectively (UMUTAAffy Hippocampus
Exon Feb09 RMA). In contrast, we detected significant
differences in the putative regulation of gene expression
that was measured across different exons in many of the
genes. For example, a cis effect for solute carrier family
35, member E1 (Slc35e1) was uncovered only by probe
sets that target the distal region of the 39-UTR and not by
the rest of the probes. These data provide additional
evidence of increased transcriptome diversity in BXD.
As considered above, variation in transcription termi-
nation and alternative splicing can give rise to discrete
quantitative differences in the steady-state mRNA level
of different isoforms between strains. When these
mRNA isoform variants (e.g., long or short 39-UTRs)
map as local QTL, we can be sure that the effect is
due to a local DNA sequence variant that will not
necessarily overlap probes but may nonetheless pro-
duce quantitative variation among isoforms. These
Figure 1.—Variation in alternative splicing
and the expression difference of Arfrp1 in stria-
tum (UTHSC Illumina 6.1: November07 data
set). Variation in expression was detected only
by a probe that targets the alternatively spliced
exon (ILM6290594) but not by a probe that tar-
gets the 39-UTR (ILM1450102). This discrepancy
is probably a result of variation in the abundance
of an alternatively spliced isoform among BXD
strains.
Figure 2.—The effect of alternative 39-UTR
processing on the expression of St6galnac4 in
striatum (UTHSC Illumina 6.1: November07).
A difference in expression was detected only by
a probe that targets the distal long 39-UTR tran-
script (ILM1090372, LRS ¼ 73.3, 1.2-fold differ-
ence) but not by probes that target the 59-UTR
(ILM4010373), exon 3 (ILM6940161), or exon
4 (ILM4920068). This discrepancy is the result
of isoform variation among BXD strains due to
multiple poly(A) sites. The heat maps are repre-
sented in ‘‘gray plus blue plus red’’ in which more
intense colors mark chromosomal regions with
comparatively high linkage statistics and the spec-
trum encodes the allelic effect. The blue–green
regions are those in which the B allele is associ-
ated with higher trait values, whereas the red–
yellow regions are those in which the D allele is
associated with higher trait values. Gray and black
regions have insignificant linkage between traits
and DNA markers. The physical location of the
gene is represented by an orange triangle.
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combined qualitative and quantitative differences are
interesting to study and can affect phenotypes in
multiple ways—by altering message stability, translation
efficiency, protein sequence, and function. For exam-
ple, a 39-UTR long-form variant in them-opioid receptor
in CXB RI strains causes a low response to morphine
agonists and higher pain sensitivity (Ikeda et al. 2001;
Han et al. 2006).
Systematic identification of genuine cis-modulated
transcripts: We developed an efficient analytical ap-
proach that combines bioinformatics and molecular
methods to filter out artifactual expression differences.
In general, a robust expression-profiling platform will
uncover a large number of cis-regulated candidates in a
segregating population. Initially, a large fraction of
apparent cis QTL are excluded on the basis of sig-
nificance of the linkage, position, and fold difference
in expression. All these steps are common to most
expression genetics analyses. In one of the CNS data
sets (Hippocampus Consortium M430v2 June06), we
identified 3810 cis-acting QTL candidates (LRS . 20)
closely mapped to the source gene (63 Mb) (Table 1,
step A). The size and direction of additive effects
were imbalanced with 66% of cis QTL associated
with higher expression of the B alleles relative to the
D alleles. A more relaxed stringency of effect size (LRS.
15) or distance between QTL and the source gene (65
Mb) did not correct the imbalance in favor of B alleles
(61%:39% to 67%:33%). If we apply the highest strin-
gencies (LRS. 20,63 Mb from source), 750 of 3810 cis
QTL have robust differences in gene expression (fold
difference .1.68). These 750 candidate cis QTL modu-
late the expression of 630 genes. The imbalance in this
reduced set of candidates favored the B over the D alleles
(60%:40%) (Table 1, step B).
We analyzed each of these transcripts at the level of
probes and probe sets to evaluate likely sources of
expression differences (Table 1, step C). We were
interested in identifying expression variation that is
solely quantitative and not a result of sequence differ-
ences overlapping probes or due to alternative splicing,
initiation, and termination of transcription. First, we
identified probes overlapping known SNPs by compar-
ing flanking positions of probes with positions of all
informative SNPs. We included this information and
flagged problematic probes, using the GeneNetwork
‘‘probe tool’’ page created for each probe set. This
procedure is frequently used by most expression genet-
ics studies (Stranger et al. 2007). Other studies simply
assess the impact of SNPs on the rate of discovery of cis-
modulated transcripts by sequencing the complemen-
tary area of probes associated with the highest effects
(Druka et al. 2008).
We are aware that a large number of sequence variants
have not been yet identified (especially indels) and
some of these can overlap probes. We used QTL Reaper
and a more refined linkage analysis of individual probe
data—the single 25-mers as opposed to the full probe
set—and examined the consistency of linkage across
individual probes and those generated by the Affyme-
trix full probe set. Alberts et al. (2007) developed a
different approach of identifying problematic probes by
decomposing the signal provided by the probe set and
analyzing the deviation of the individual probes from
the entire set. A computational protocol that flags
probes that may overlap SNPs is freely available in R
(Alberts et al. 2008). The end result of both ap-
proaches is similar and neither of the methods requires
a priori information on SNP location. Our approach and
resequencing data revealed many examples of artifac-
tual expression variation due to overlaps between
probes and sequence variants.
We assumed that a large fraction of expression
differences are due to isoform variation as a result of
TABLE 1
Filtering process of the cis QTL candidates in the hippocampus of BXD




(B vs. D ratio, %)
Affymetrix M430 v2.0 array data set 45,101 (23,080) 47:53
A. cis QTL (LRS . 20, QTL mapped 6 3 Mb from source) 3,810 (2,856) 66:34
cis QTL (LRS . 20, QTL mapped 6 5 Mb from source) 4,117 (3,064) 67:33
cis QTL (LRS . 15, QTL mapped 6 3 Mb from source) 4,416 (3,279) 61:39
cis QTL (LRS . 15, QTL mapped 6 5 Mb from source) 4,844 (3,548) 65:35
B. cis QTL (LRS . 20, QTL mapped 6 3 Mb from source)
fold difference between allelic expression .1.7
750 (630) 60:40
C. Probes associated with potentially true cis QTL—filtering
out the remaining 440 cis QTL was based on:
190 (166) 49:51
Potential SNP overlapping probes (70%) 308 (302) 74:23
Alternative 39-UTR processing (14%) 62 (62) 76:24
Alternative splicing (10%) 44 (44) 72:28
Other (6%) 26 (25) 64:36
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events such as alternative splicing, initiation, or termi-
nation of the transcription. We used EST/cDNA se-
quences from various sources, identified their position
in the mouse genome, and compared the predicted gene
structures at each locus for detection of possible isoform
variants. We determined that a considerable fraction of
the probe sets target areas that are polymorphic between
isoforms, which vary between strains, especially at the
distal end of the 39-UTR. In CNS tissues this can become
an important confound, because genes tend to express
longer transcripts and 39-UTRs (Zhang et al. 2005) and
exhibit higher levels of alternative splicing than other
tissues (Yeo et al. 2004).
Following all these bioinformatics analyses we pre-
dicted that the expression differences of 190 of the 750
candidates (25%) are solely quantitative and a result of
cis modulation. Probes that target these transcripts will
map cis irrespective of their location relative to different
regions of the transcript. In this group of 190 candidates
we were able to regain close to a 1:1 balance between B
and D alleles (B vs. D, 49.2–50.8%, Table 1). In contrast,
we predicted that the remaining 440 potentially cis-
modulated transcripts are mainly a result of SNPs or
other sequence variation (known and unknown) that
overlap probes (70%), 39-UTR processing, (14%) and
alternative splicing (10%). The imbalance in the di-
rection of the additive effect is significantly higher in
favor of B alleles in all of these categories that affect
expression measurements. We excluded all cis QTL
candidates on the basis of probes that overlap known
SNPs or probes with inconsistent linkage across the set
due to potential unknown sequence variants. We fil-
tered out the probes that detect combined qualitative
and quantitative differences between isoforms in a
distinct group and used them separately in validation
studies and downstream analyses.
A large number of genuine cis-regulated transcripts
were probably excluded by our filtration process due to
overly stringent criteria. For example, the number of
candidate cis-modulated transcripts could be increased
to 5000 by simply selecting all transcripts with a local cis
LRS. 10 or by extending the allowed distance between
the source gene and the QTL. While this procedure will
boost the final number of candidates, it will also
increase the false discovery rate (FDR). The FDR at
other stages of our filtration process could be de-
termined empirically by measuring allelic expression
or by similar procedures using sets of randomly selected
transcripts from each step.
Validation of cis variation by ASE: The ASE approach
provides a relatively unambiguous measure of expression
variation generated by cis-acting factors (Doss et al. 2005).
From the short list of 190 putative cis-acting QTL de-
scribed above we selected 43 candidates for ASE analysis
(Figure 3 and Table S4). These candidates vary in their
effect and significance and cover most chromosomes
(Figure 3). They also provide sufficient statistical power
to predict the true distribution of the 190 cis candidates.
ASE of at least 40 candidate QTL is required to predict
with sufficient accuracy the true distribution of the entire
set of 190 cis QTL (95% confidence interval $j0.15j).
We used reciprocal C57BL/6J 3 DBA/2J F1 hybrids
and SNPs in which the expression of both alleles can be
quantified simultaneously in single samples. If the
variation in expression of a particular transcript is a
result of genuine cis modulation, the expression of B
and D alleles will be significantly different in F1 hybrids.
If the variation in expression across BXD strains is a
result of trans modulation or is simply an artifact, no
difference in allelic expression will be observed in
hybrids. While the trans effects remain in F1 individuals,
the difference in allelic expression will not be detected
since both allelic trans factors (B and D) are part of the
same cell and have equal access to their downstream
targets. We intentionally selected SNPs that are shared
by most or all mRNA isoforms, to capture quantitative
differences in expression rather than structural differ-
ences among isoforms.
Fold difference in expression and the significance of
cis modulation vary considerably among transcripts. We
Figure 3.—Chromosomal distribution and
the significance of self-linkages for 43 transcripts
selected for ASE quantification. The size and the
direction of the additive genetic effect (a) were
estimated using ‘‘INIA Brain mRNA M430:
January06’’ data and are represented by lines next
to the LRS circles. The additive effect is measured
on a log2 scale in which one unit corresponds ap-
proximately to a twofold difference. A line above
the LRS circles indicates that D alleles increase
trait values. In contrast, a line below the circles
indicates that B alleles increase the trait. The fold
difference in expression between parental alleles
ranges from 0.29 to 3.23. The significance of the
linkage varies from 16 to 110. The selected genes
are located in all but three of the somatic chro-
mosomes (Table S4). Solid circles represent
genes that failed to show by ASE a significant dif-
ference in expression in F1 individuals.
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confirmed that 33 (77%) of 43 genes are genuinely cis
modulated at P, 0.05 and that 81% are cismodulated at
P , 0.1. If we apply the properties of the binomial
distribution, the 95% confidence interval of the valida-
tion rate in the entire set of 190 genes will be between 66
and 88%. We performed a statistical evaluation of the
LRS score effect on true positive prediction of cis QTL.
While at first glance a LRS threshold of at least 60 seems
to improve the number of genuine cis QTL (Figure 3),
we did not identify any significant statistical relationship
between LRS and the validation results. Directions of
allelic effects agreed in all cases with our array data.
Furthermore, the percentage of validation was inde-
pendent of the polarity of the effect (77% for B and 76%
for D alleles).
We estimated the fraction of genuine cis-modulated
transcripts by applying our ASE validation rate with the
assumption that the bias in favor of B-allele effects is
generated entirely by sequence variants that affect
probe signal. In the original set of 750 cis-acting QTL
the imbalance favored B over D QTL by a ratio of 3/2.
This imbalance indicates that one-third of B-positive cis
effects are false, assuming that all D-positive cis effects
are true. After we apply the ASE validation rate, the
estimated fraction of true cis-modulated transcripts is
51% for B-positive and 77% for D-positive alleles.
Sequence variation and the universal biases in
genetic expression studies: It is important to note that
even in the absence of an explicit imbalance in allelic
effects seen in the BXD panel, the same problems and
challenges apply with equal force in other population
resources. For example, in the LXS panel there is a
perfect balance between cis QTL with high levels of L vs.
high levels of S alleles since both L and S haplotypes
share roughly the same fraction of the B haplotype used
to design microarrays. However, in this cross, there is a
similar fraction of artifactual expression variation, but
the source is shared equally by both parental strains.
After taking into account the sample size, parental strain
genetic differences, and the choice of microarray
platform, we estimate that in the hippocampus data
set of 3810 candidate cis QTL there are at least 1000
genuine QTL responsible for a fold difference in
expression .50% (Hippocampus Consortium M430v2
June06).
Downstream analysis of cis-modulated variation: The
possibility of quantifying gene expression in segregating
populations provides an opportunity to infer relation-
ships between genes and their transcripts. Another
objective of this study is to show the potential of system
genetics to identify downstream targets of cis modula-
tion and the impact on higher-order phenotypes.
Some of the cis-modulated transcripts validated by
ASE have roles in CNS development and neurotrans-
mission and are potential candidates for behavioral
traits and neurological diseases. It would be interesting
to know if any of these expression differences are large
enough to lead to quantitative differences at the protein
level that could ultimately trigger variation in behavior
and disease susceptibility. For example, serine threo-
nine kinase 25 (Stk25) is known to be involved in a
pathway that leads to cerebral cavernous malformation
(CCM) in humans (Voss et al. 2007). Human STK25
interacts directly with the products of two genes
associated with CCM: CCM2 and CCM3 (Voss et al.
2007). In agreement with these results we detected
moderate to high correlations between expression of
Stk25 and expression of three mouse orthologs of the
CCM genes (Table 2). We uncovered a locus responsible
for the variation in the expression of all three tran-
scripts—Krit1 (Ccm1), Ccm2, and Pdcd10 (Ccm3)—that
maps to chromosome (Chr) 1 between 90 and 100 Mb,
the precise location of Stk25, strongly implicating Stk25
as the source of expression difference (Figure 4). We
then used a global method to generate a list of other
downstream targets of Stk25 (Table S5). All of the targets
presented in Table 2 have a correlation with Stk25 of at
least 0.45 in one of the CNS tissues and at least 0.25 in
three or more tissues. These potential targets have
moderate to strong QTL that overlap Stk25. Finally,
all targets have strong correlations with Stk25 purely
on the basis of an analysis of their shared literature
(Homayouni et al. 2005). For example, Stk25 is related
by expression, by QTL, and by literature with Stk4.
Over the years the BXD panel has been extensively
phenotyped for many pharmacological, anatomical,
and behavioral traits, and these data are available in
GeneNetwork. We explored if variation in expression of
Stk25 correlates with any of these traits. Since Stk25 is
linked to brain vascularization, it is noteworthy that the
top correlates of Stk25 are all neural and behavioral
traits. The expression of Stk25 is highly correlated with
the initial sensitivity to ethanol-induced ataxia (r¼ 0.70,
P , 0.001; GeneNetwork trait ID, 10144) and cerebel-
lum volume (r ¼ 0.48, P , 0.05; trait ID, 10004) and
moderately correlated with many traits associated with
motor activity in an open field such as vertical activity
(r ¼ 0.48, P , 0.0001; trait ID, 11863) or distance
traveled in a novel environment (r¼ 0.36, P, 0.01; trait
ID, 11602).
RASD family, member 2 (Rasd2) is another cis-
modulated gene that exhibits a significant difference
in expression in the BXD panel. Rasd2 is a member of
the Ras GTPase family of proteins that controls pathways
involved in synaptic plasticity, learning, and memory
(Spano et al. 2004).Rasd2 is predominantly expressed in
striatum but also in other areas of the brain such as
hippocampus. We detected a moderate correlation
between the expression of Rasd2 and the adhesion
molecule with the Ig-like domain 2 gene (Amigo2, r ¼
0.41) in hippocampus. Amigo2 is located on Chr 15 at
97.1 Mb and is trans-modulated by a locus on Chr 8 at
78.7 Mb (LRS¼ 27), very close toRasd2 (Chr 8, 78.1 Mb).
This transQTL is responsible for15% of the variation in
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expression of Amigo2 in hippocampus. The confidence
limits of the QTL extend from 78 to 79.2 Mb and include
only three genes: Rasd2, Mcm5, and 1700007B14Rik. We
examined expression patterns of these genes and Amigo2
using in situ data available from Allen Brain Atlas
(www.brain-map.org). Mcm5 and 1700007B14Rik have
low expression in the brain and are less interesting
candidates for the Amigo2 trans QTL. In contrast, variants
in Rasd2 could clearly influence Amigo2 expression.
Rasd2 exhibits regional expression in the hippocampus,
high in both CA1 and CA3, but little to none in CA2.
Amigo2 shows complementary regional differences with
high expression in CA2, but almost none in CA1 or CA3,
supporting a repressive influence of Rasd2 on Amigo2
expression (Figure 5).
To test the hypothesis that Rasd2 expression consis-
tently represses expression of Amigo2 we analyzed 10
other CNS regions in which Rasd2 is expressed. A
complementary pattern of high expression of Rasd2
and low to absent expression of Amigo2 was found in 8 of
the 10 areas: the pyramidal cell layer of fields CA1 and
CA3 of the hippocampus, the dorsal striatum, the mitral
layer and periglomerular cells of the main olfactory
bulb, the olfactory tubercle, the substantia nigra pars
compacta, the entorhinal cortex, and the reticular
nucleus of the thalamus. We did not detect the same
pattern for the hilus of the hippocampus or for the
paraventricular nucleus of the thalamus. The presence
of the Amigo2 trans QTL on Chr 8 and the relatively
consistent complementary expression pattern and cor-
relation provide cumulatively strong support for the
hypothesis that Rasd2 is an inhibitor of Amigo2.
Rasd2 is known to be regulated by thyroid hormones
(Errico et al. 2008) and interestingly we found the ex-
pression of its potential downstream target—Amigo2—to
be highly correlated with total serum thyroxine (r¼ 0.87,
P, 0.005; trait ID, 10602). The expression of Amigo2 was
shown to promote the survival of cerebellar granule
neurons and was considered a candidate for familial
Alzheimer’s disease type 5 (Ono et al. 2003). We found
the expression of Amigo2 to be highly correlated with the
granule cell number in hippocampus (r ¼ 0.76, P ,
TABLE 2
Expression and literature correlations between transcripts with trans QTL located on Chr 1 (90 and 100 Mb) and Stk25







Stk25 1416770_at 59041 1.00 (0) 1.00 96.2
Actr3 1452051_at 74117 0.54 (0.00014) 0.42 11.9
Ankrd6 1437217_at 140577 0.57 (3.64e-05) 0.44 15.1
Ccm1 1448701_a_at 79264 0.48 (1.01e-0.3)S 0.55 9.2
Ccm2 1456290_x_at 216527 0.54 (0.00013) 0.63 8.7
Ccm3 1448527_at 56426 0.37 (1.39e-02) N.A. 8.7
Chordc1 1460645_at 66917 0.49 (0.00075) 0.58 14.7
Hspe1 1450668_s_at 15528 0.51 (0.00043) 0.52 13.7
l7Rn6 1419351_a_at 67669 0.72 (2.67e-09) 0.51 22.5
Oaz1 1436292_a_at 18245 0.47 (0.00139) 0.49 13.0
Stk4 1436015_s_at 58231 0.47 (0.00034) 0.78 11.7
Tmco1 1423759_a_at 68944 0.52 (0.00031) 0.53 14.4
Ubr5 1452718_at 70790 0.47 (0.00113) 0.57 12.6
Figure 4.—Downstream potential targets of serine threo-
nine kinase 25 (Stk25). Stk25 is located on Chr 1 at 95.4 Mb
and is cis-modulated in brain (LRS ¼ 96.1, INIA Brain mRNA
M430: January06, probe set 141770_at). Several potential tar-
gets of Stk25 have relatively strong trans QTL that overlap
Stk25 (heat map conventions are as in Figure 2). All these tar-
gets have a correlation with Stk25 of at least 0.45 in whole brain
and a shared literature correlation of at least 0.42 (Table
2). Most of these transcripts share a trans QTL located on
Chr 4.
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0.001; trait ID, 10337) and with the volume of the dorsal
(r ¼ 0.48, P, 0.01; ID, 10755), and ventral hippocam-
pus (r ¼ 0.47, P , 0.01; trait ID, 10757). Rasd2 was
found recently to affect another neurogenerative disor-
der—Huntington’s disease—by interacting with the mu-
tant allele of huntingtin (Subramaniam et al. 2009).
Next-generation eQTL studies: While the methods
we have described here provide an effective way to
correct for problems associated with array-based mea-
surement of expression, there are more satisfying
solutions that are now on the horizon. Massively parallel
sequencing of RNA samples (e.g., Mortazavi et al.
2008) represents a more direct way to measure steady-
state abundance of mRNAs. RNA sequencing (RNA-
seq) has three potential benefits in eQTL studies. First,
this method is comparatively insensitive to sequence
differences among individuals in segregating popula-
tions. SNPs and short indels should not have a signifi-
cant impact on the alignment and identification of 50-nt
mRNA tags. Second, this method can resolve the relative
expression of mRNA isoforms and will enable the
genetic dissection of splice variants and alternative
UTRs. Finally, this method can be multiplexed more
easily than array-based methods. It will be practical to
sequence pools of RNA from many samples in single
runs. This should reduce technical confounds in large
experimental designs that are so common in this field.
We are now beginning to exploit this approach by
profiling expression in the parental strains of the BXD
RIs—a step that should allow us to recalibrate first-
generation eQTL studies.
In this report we have developed and tested a protocol
to systematically extract, study, and validate DNA se-
quence variants that are responsible for differences in
mRNA abundance in a RI population. We have done
this by combining gene expression profiling with a
collection of bioinformatics routines and molecular
techniques, including qRT-PCR, ASE, and resequenc-
ing. Our study demonstrates that both quantitative and
qualitative variation contributes to the mRNA diversity
in segregating populations. In particular, we have
focused our work on cis-acting QTL. Validated cis
variations are in essence more subtle and natural forms
of standard genetically engineered mutants. Rather
than completely inactivating gene expression of a gene
on a single strain background, these alleles modulate
expression over a 2- to 20-fold range across a panel of
readily available strains. As we have exemplified above,
once validated, these allelic expression differences can
be used in reverse genetic studies to generate well-
defined hypotheses regarding downstream effects on
molecular, cellular, and functional networks.
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